Research progress on radiotherapy for brain metastasis from non-small-cell lung cancer with ALK rearrangement / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 467-471, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-755052
ABSTRACT
Brain metastasis is common in non-small-cell lung cancer (NSCLC) with driver gene mutations.At present,brain radiotherapy combined with tyrosine kinase inhibitor (TKI) is a hot topic.Anaplastic lymphoma kinase (ALK) gene rearrangement is one of the common driver mutations in NSCLC.However,the treatment of brain metastasis from NSCLC with ALK gene rearrangement has been rarely investigated.The prognosis of these patients,the role of brain radiotherapy and the proper comb ination of radiotherapy with ALK-TKI are worthy of further exploration.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Radiation Oncology
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS